BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35850307)

  • 1. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS.
    Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA
    J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains.
    Chen CX; Cho DS; Wang Q; Lai F; Carter KC; Nishikura K
    RNA; 2000 May; 6(5):755-67. PubMed ID: 10836796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
    Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
    Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.
    George CX; Ramaswami G; Li JB; Samuel CE
    J Biol Chem; 2016 Mar; 291(12):6158-68. PubMed ID: 26817845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine Deaminases Acting on RNA (ADARs) and Viral Infections.
    Pfaller CK; George CX; Samuel CE
    Annu Rev Virol; 2021 Sep; 8(1):239-264. PubMed ID: 33882257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
    Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
    Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine Deaminase Acting on RNA (ADAR) Enzymes: A Journey from Weird to Wondrous.
    Keegan LP; Hajji K; O'Connell MA
    Acc Chem Res; 2023 Nov; 56(22):3165-3174. PubMed ID: 37906879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2.
    Ishiguro S; Galipon J; Ishii R; Suzuki Y; Kondo S; Okada-Hatakeyama M; Tomita M; Ui-Tei K
    RNA Biol; 2018; 15(7):976-989. PubMed ID: 29950133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
    Fritzell K; Xu LD; Lagergren J; Öhman M
    Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine-to-inosine RNA editing by ADAR1 is essential for normal murine erythropoiesis.
    Liddicoat BJ; Hartner JC; Piskol R; Ramaswami G; Chalk AM; Kingsley PD; Sankaran VG; Wall M; Purton LE; Seeburg PH; Palis J; Orkin SH; Lu J; Li JB; Walkley CR
    Exp Hematol; 2016 Oct; 44(10):947-63. PubMed ID: 27373493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation.
    Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150.
    Pfaller CK; Donohue RC; Nersisyan S; Brodsky L; Cattaneo R
    PLoS Biol; 2018 Nov; 16(11):e2006577. PubMed ID: 30496178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR1 Stimulation by IFN-α Downregulates the Expression of MAVS via RNA Editing to Regulate the Anti-HBV Response.
    Li T; Yang X; Li W; Song J; Li Z; Zhu X; Wu X; Liu Y
    Mol Ther; 2021 Mar; 29(3):1335-1348. PubMed ID: 33279720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
    Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
    Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.
    Samuel CE
    J Biol Chem; 2019 Feb; 294(5):1710-1720. PubMed ID: 30710018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
    Liddicoat BJ; Chalk AM; Walkley CR
    Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
    de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
    Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
    Toth AM; Li Z; Cattaneo R; Samuel CE
    J Biol Chem; 2009 Oct; 284(43):29350-6. PubMed ID: 19710021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.